DCRI to Help Understand How Existing Drugs can Improve Symptoms and Clinical Outcomes for People with COVID-19
The DCRI has received $44 million in funding to examine whether three immune modulators help prevent overactive immune response in moderate or severe cases of COVID-19.
ABC Science Collaborative to Lead New Study on COVID-19 Testing in Schools
The study includes both surveillance and exposure testing to reduce COVID-19 transmission and interviews with families to increase trust within communities.
DCRI Strength in Building Networks Highlighted by Antibacterial Resistance Leadership Group Achievements
The Antibacterial Resistance Leadership Group (ARLG) involves over 100 experts, generating over 155 papers and initiating 55+ studies with 21,000 participants at 130 sites in 12 countries.
Study Shows Importance of Patient-Reported Outcomes in Heart Failure Care
More than twice as many patients saw changes in their patient-reported outcome measures compared with their traditional NYHA measures used by clinicians.
DCRI to Co-Lead Program for Self-Administered COVID-19 Testing
The program will evaluate testing results and other data to determine whether the intervention of providing self-administered COVID-19 tests helps to slow the rate of community transmission.
One Year Later: The ABC Science Collaborative Provides Evidence that Helps To Open North Carolina Schools
North Carolina models the way for national discussion and decisions on school re-openings during COVID-19 pandemic.
Pragmatic Approaches Enable Lower Burden and Cost in DCRI-led Trial
The HiLo study seeks to determine the optimal phosphate level for patients with chronic kidney disease.
The ABCs of Keeping Kids Healthy
The below is a republication of a story that featured DCRI’s Kanecia Zimmerman, MD, MPH, which appeared in Duke University School of Medicine’s digital publication, Magnify.
Study Shows ‘Alarming Gaps’ in Treatment of Patients with Diabetes, Heart Disease
Over a third of patients with diabetes and heart disease were not taking any of the three therapies proven to prevent major adverse cardiovascular events.
DCRI Statistician Advocates for Open Science During COVID-19
A recent letter to the editor provided recommendations for encouraging open science in COVID-19 clinical trials, such as incentives for data sharing during the project funding stage.